Evidence map›Paper›PMID 29760395›Full record

ArticleScientific reports2018

Silver nanoparticles promote the emergence of heterogeneic human neutrophil sub-populations.

Jennifer A Fraser, Sadie Kemp, Lesley Young, Mark Ross, Morag Prach, Gary R Hutchison, Eva Malone

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Club Cell Protein 16 Attenuates CD16Journal of immunology research · 2021
    Article
  14. Review
  15. CD62LFrontiers in oncology · 2020
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jennifer A FraserSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK. j.fraser@napier.ac.uk.ORCID 0000-0001-5546-3916
Sadie KempSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK.
Lesley YoungSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK.
Mark RossSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK.ORCID 0000-0002-0204-3915
Morag PrachSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK.
Gary R HutchisonSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK.
Eva MaloneSchool of Applied Sciences, Edinburgh Napier University, Sighthill Campus, Edinburgh, EH11 4BN, UK. e.malone@napier.ac.uk.
Edinburgh Napier University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil surveillance is central to nanoparticle clearance. Silver nanoparticles (AgNP) have numerous uses, however conflicting evidence exists as to their impact on neutrophils and whether they trigger damaging inflammation. Neutrophil's importance in innate defence and regulating immune networks mean it's essential we understand AgNP's impact on neutrophil function. Human neutrophil viability following AgNP or Ag Bulk treatment was analysed by flow cytometry and AnV/PI staining. Whilst AgNP exposure did not increase the total number of apoptotic neutrophils, the number of late apoptotic neutrophils was increased, suggesting AgNP increase transit through apoptosis. Mature (CD16

Indexed as

Up-RegulationCell SurvivalFlow CytometryHumansInterleukin-8L-SelectinMetal NanoparticlesNeutrophil ActivationNeutrophilsReceptors, IgGSilverCXCL8 protein, humanInterleukin-8L-SelectinReceptors, IgGSELL protein, humanSilver

Identifiers

PMID29760395
PMCPMC5951814
OpenAlexW2801128206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.